Feature

Patient advocacy groups take in millions from drugmakers. Is there a payback?


 


“I never went to a meeting,” Raymond said. “A former employee signed us up for a whole host of coalitions. I think we put our name on something or someone did.”

She said the Lupus Foundation was no longer a member of the coalition. Days after Kaiser Health News reached out to the coalition, its website was updated, excluding the Lupus Foundation.

For its part, AbbVie – which overall donated $24.7 million to patient groups in 2015, according to the new database – stipulates that its grants to nonprofits are “non-promotional” and provide no direct benefit to its business, according to a company statement. The company gives to patient groups because they serve as an “important, unbiased and independent resource for patients and caregivers.”

Insulin and influence

The American Diabetes Association said in an email to KHN that it received $18.3 million in pharmaceutical funding in 2017, accounting for 12.3% of its revenue; that was down from $26.7 million in 2015. The money flowed in as insulin makers continued to hike prices in those years – up to four times per product – leading to hardships for patients.

Pages

Recommended Reading

MDedge Daily News: How European data privacy rules may cost you
MDedge Dermatology
Patients who hide. Patients who seek.
MDedge Dermatology
MDedge Daily News: How gastric bypass helps fight diabetes
MDedge Dermatology
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Dermatology
Cutting Edge Technology in Dermatology: Virtual Reality and Artificial Intelligence
MDedge Dermatology
Medicare Part D plans get more flexibility to make midyear changes
MDedge Dermatology
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Dermatology
Open enrollment 2018: Plan selections down slightly
MDedge Dermatology
MDedge Daily News: Antibiotic resistance leads to ‘nightmare’ bacteria
MDedge Dermatology
Health IT ‘under-users’ outnumber ‘super-users’
MDedge Dermatology